A system for treating a bifurcation includes a first radially expandable stent and a second radially expandable stent. The first stent has a side hole and a plurality of lateral elements extending from the side hole. The second stent has a plurality of axial elements extending away from the proximal end of the second stent. The axial elements of the second stent interdigitate with the lateral elements of the first stent when both stents have been expanded.

The invention relates to oligofluorinated coatings and their use in drag delivery. The oligofluorinated coatings are compositions comprising formula (XVII). These coatings are used in a method of delivering a biologically active agent to a tissue surface in a mammalian tissue. This method occurs by contacting the surface with the coating including an oligofluorinated oligomer and a biologically active agent wherein the coating resides on the tissue surface and release the biologically active agent to the tissue surface.

A dual guidewire lumen catheter includes a first elongated member and a second elongated member. The first elongated member includes a first integral portion, a first free portion, and a first lumen extending there through. The first lumen is configured to receive a first guidewire. The first free portion has a first distal end and a first aperture configured to receive the first guidewire. The second elongated member includes a second distal end and a second lumen there through. The second lumen is configured to receive a second guidewire and the second distal end has a second aperture configured to receive the second guidewire. The second elongated member is integral with the first integral portion of the first elongated member and the first free portion is moveable with respect to a central axis of the catheter.

Methods for the diagnosis and treatment of nonstenotic carotid plaques and symptomatic nonstenotic carotid disease (SyNC) are described. In particular, methods of evaluating the presence of unstable plaque/thrombus and methods of treatment that include deploying plaque stabilizers (PSs) into the cerebral vasculature are described. The invention further describes plaque stabilizers, uses of plaque stabilizers and plaque stabilizer kits.

Devices, systems for localized delivery of a chemotherapy, hormonal therapy or targeted drug/biologic therapy to a target tissue area of an internal body organ of a patient. A catheter 10 forms a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin. The drug may saturate the target tissue area and pass therethrough into the lymphatic system or interstitial space, which may serve as a reservoir of the drug for continued therapeutic treatment after withdrawal of the catheter. The chamber is evacuated at the end of the treatment session.

A device for providing antegrade vascular access through retrograde approach is disclosed. The device includes a balloon arranged on a sheath and one or more side holes formed in the sheath proximal of the balloon. The balloon may be bulbous. A method for providing antegrade vascular access through retrograde approach is also disclosed.

A multi-purpose balloon catheter includes a catheter having a proximal end portion, a central portion and a non-branching distal end portion, a plurality of lumens associated with the catheter extending from the proximal end portion, and a plurality of inflatable balloons positioned in the central portion and/or the non-branching distal end portion. Each of the plurality of inflatable balloons is communicatively associated with a corresponding one of the plurality of lumens, the plurality of inflatable balloons being selectively inflated or deflated to position and stabilize the catheter in a cavity for delivery of a medical treatment. The catheter can include an extraction point associated with a lumen to remove fluids and materials from the cavity, and a connector associated with a corresponding lumen adapted to selectively receive one or more of a fluid medium or a radioactive isotope provided to a corresponding lumen for delivery of the medical treatment.

Tortuosity of vessels at or leading to the site of minimally invasive procedures is a problem for conducting such procedures as they increase the difficulty to guide the procedural catheters through tortuous vessels. Methods and apparatus for stabilization of the sheaths and catheters during access, procedures, and withdrawal in these tortuous vessels are disclosed. The apparatus and method for improving access include application of a pull component to the stabilized procedural catheter using a stabilization catheter/wire in addition to a push component from the percutaneous access to make the access easier while enabling use of more flexible catheters and softer wires. These methods and devices address the problems of trauma to the vessels during access, procedure and removal of catheters and wires, improve pushability of softer catheters and wires, and also substantially reduce substantially the procedure time.

A gastrostomy tube for enteral nutrition or medication of a subject, comprising a dual lumen first flexible tube with an internal retention device at an internal end and a substantially Y-shaped connector at an external end. A single lumen second flexible tube is connected at a first end to a main longitudinal channel of the dual lumen tube via the substantially Y-shaped connector. A second end of the second flexible tube is connectable to a nutrient or medicine source. The invention also relates to a kit of parts comprising a gastrostomy tube and a nutrient/medicine container attachable to the gastrostomy tube.

An apparatus and methods for use are provided, where the apparatus includes: (a) a first catheter having a proximal end and a distal end, and wherein a distal portion of the first catheter includes a first one or more outlets, (b) a first tubular housing having a proximal end and a distal end, wherein the first tubular housing is coupled to the first catheter proximal to the at least one first outlet, (c) one or more pressure sensors coupled to the distal end of the first tubular housing, and (d) a second catheter having a proximal end and a distal end, wherein a distal portion of the second catheter includes a second one or more outlets, and wherein the distal end of the second catheter is configured to be positioned substantially within one of (i) the first catheter or (ii) a second tubular housing coupled to one or more of the first catheter and the first tubular housing, when the second catheter is in a first position.